AMGN vs REGN
AMGN and REGN side by side — valuation & fundamentals (public data).
Key statistics
| Metric | AMGNAmgen Inc. | REGNREGENERON PHARMACEUTICALS, INC. |
|---|---|---|
| Market cap | $201.83B | — |
| P/E (TTM) | 26.0 | 16.0 |
| P/B | 21.96 | — |
| Dividend yield | 2.54% | — |
| Revenue | $37.22B(TTM) | $14.92B(TTM) |
| Net income | $7.80B(TTM) | $4.42B(TTM) |
| EPS, diluted | $14.37(TTM) | $40.96(TTM) |
Figures from SEC filings · for reference only · not investment advice
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)